Search Ontology:
ChEBI

1-[(13Z,16Z)-docosadienoyl]-2-hexadecanoyl-sn-glycero-3-phospho-1D-myo-inositol

Term ID
CHEBI:89246
Synonyms
  • (2R)-2-(hexadecanoyloxy)-3-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propyl (9Z,12Z)-docosa-13,16-dienoate
  • 1-(13Z,16Z-docosadienoyl)-2-hexadecanoyl-glycero-3-phospho-(1'-myo-inositol)
  • 1-(13Z,16Z-Docosadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol)
  • 1-[(13Z,16Z)-docosadienoyl]-2-palmitoyl-sn-glycero-3-phospho-1D-myo-inositol
  • 1-Docosadienoyl-2-palmitoyl-sn-glycero-3-phosphoinositol
  • Phosphatidylinositol(22:2/16:0)
  • Phosphatidylinositol(22:2n6/16:0)
  • Phosphatidylinositol(22:2w6/16:0)
  • Phosphatidylinositol(38:2)
  • PI(22:2(13Z,16Z)/16:0)
  • PI(22:2/16:0)
  • PI(22:2n6/16:0)
  • PI(22:2w6/16:0)
  • PI(38:2)
  • PIno(22:2/16:0)
  • PIno(22:2n6/16:0)
  • PIno(22:2w6/16:0)
  • PIno(38:2)
Definition
A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (13Z,16Z)-docosadienoyl and hexadecanoyl respectively.
References
  • HMDB:HMDB0009905
  • LIPID_MAPS_instance:LMGP06010731
  • PMID:20671299
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from 1-[(13Z,16Z)-docosadienoyl]-2-hexadecanoyl-sn-glycero-3-phospho-1D-myo-inositol
Phenotype where environments contain 1-[(13Z,16Z)-docosadienoyl]-2-hexadecanoyl-sn-glycero-3-phospho-1D-myo-inositol
Phenotype modified by environments containing 1-[(13Z,16Z)-docosadienoyl]-2-hexadecanoyl-sn-glycero-3-phospho-1D-myo-inositol
Human Disease / Model Data